Free Trial

Marpai (MRAI) Competitors

Marpai logo
$1.35 +0.13 (+10.66%)
As of 07/9/2025 03:54 PM Eastern

MRAI vs. NAKA, KDLY, QIPT, ATPC, OPGN, PIII, BDSX, BNR, BMGL, and CCM

Should you be buying Marpai stock or one of its competitors? The main competitors of Marpai include KindlyMD (NAKA), Kindly MD (KDLY), Quipt Home Medical (QIPT), Agape ATP (ATPC), OpGen (OPGN), P3 Health Partners (PIII), Biodesix (BDSX), Burning Rock Biotech (BNR), Basel Medical Group (BMGL), and Concord Medical Services (CCM). These companies are all part of the "healthcare" industry.

Marpai vs. Its Competitors

Marpai (NASDAQ:MRAI) and KindlyMD (NASDAQ:NAKA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Marpai has a net margin of -85.70% compared to KindlyMD's net margin of -177.01%. Marpai's return on equity of 0.00% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Marpai-85.70% N/A -100.23%
KindlyMD -177.01%-146.26%-109.19%

KindlyMD has lower revenue, but higher earnings than Marpai. KindlyMD is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marpai$34.87M0.64-$28.75M-$1.82-0.74
KindlyMD$2.72M27.38-$3.62M-$0.77-16.04

Marpai has a beta of 4.68, meaning that its share price is 368% more volatile than the S&P 500. Comparatively, KindlyMD has a beta of 35.16, meaning that its share price is 3,416% more volatile than the S&P 500.

49.8% of Marpai shares are owned by institutional investors. 61.3% of Marpai shares are owned by insiders. Comparatively, 50.5% of KindlyMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, KindlyMD had 1 more articles in the media than Marpai. MarketBeat recorded 1 mentions for KindlyMD and 0 mentions for Marpai. Marpai's average media sentiment score of 0.00 equaled KindlyMD'saverage media sentiment score.

Company Overall Sentiment
Marpai Neutral
KindlyMD Neutral

Summary

Marpai beats KindlyMD on 7 of the 12 factors compared between the two stocks.

Get Marpai News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRAI vs. The Competition

MetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ Exchange
Market Cap$22.32M$52.03M$13.02B$8.95B
Dividend YieldN/AN/A2.70%4.04%
P/E Ratio-0.510.4328.8920.16
Price / Sales0.640.35409.36173.08
Price / CashN/A2.8026.3757.97
Price / Book-0.780.096.215.62
Net Income-$28.75M$43.11M$188.52M$248.50M
7 Day PerformanceN/A-41.37%0.87%4.49%
1 Month PerformanceN/A-36.63%2.73%7.03%
1 Year Performance92.86%-5.14%38.91%21.07%

Marpai Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRAI
Marpai
N/A$1.35
+10.7%
N/A+92.8%$22.32M$34.87M-0.51150
NAKA
KindlyMD
N/A$13.61
-1.7%
N/AN/A$83.48M$2.72M-17.68N/ANews Coverage
Positive News
KDLY
Kindly MD
N/A$13.85
-3.0%
N/A+426.9%$83.38M$2.47M-17.98N/AGap Up
QIPT
Quipt Home Medical
2.9343 of 5 stars
$1.75
-2.2%
$2.85
+62.9%
-36.3%$77.76M$245.91M-8.331,200Analyst Revision
ATPC
Agape ATP
0.2439 of 5 stars
$1.33
+0.8%
N/A-64.4%$66.01M$1.32M-2.2240News Coverage
OPGN
OpGen
N/A$4.76
-0.4%
N/A+59.2%$47.92M$2.67M0.00100Gap Down
PIII
P3 Health Partners
2.9097 of 5 stars
$6.34
+0.6%
$16.25
+156.3%
-74.4%$45.28M$1.50B-0.13500
BDSX
Biodesix
3.388 of 5 stars
$0.29
+1.7%
$1.75
+509.8%
-80.5%$41.36M$71.32M-0.99220Gap Up
BNR
Burning Rock Biotech
N/A$3.20
+1.3%
N/A-30.3%$34.01M$70.67M-1.691,390
BMGL
Basel Medical Group
N/A$1.61
-9.6%
N/AN/A$32.85MN/A0.0036Gap Up
CCM
Concord Medical Services
0.8478 of 5 stars
$5.70
+3.4%
N/A-40.4%$24.88M$52.60M0.00970Gap Down

Related Companies and Tools


This page (NASDAQ:MRAI) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners